Dr. Rama Hritani, MD

Dr. Hritani practices at Advocate South Suburban Hospital - Mammography in Hazel Crest, Illinois.

Dr. Hritani's NPI, 1548623184, was assigned on March 31, 2016. Dr. Hritani holds Illinois license 036-168477.

Dr. Hritani's primary practice is Advocate South Suburban Hospital - Mammography, at 17800 S Kedzie Ave., Hazel Crest, IL 60429. The practice phone is (708) 213-3355.

Dr. Hritani's primary practice is Advocate South Suburban Hospital - Mammography in Hazel Crest, Illinois. Dr. Hritani is also affiliated with Advocate Christ Medical Center. The medical group on file is Dreyer Medical Clinic (Advocate Medical Group). Dmand AI also links Dr. Hritani to 2 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hritani practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Hritani's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Hritani's licenses on file in 2 states: Illinois and Georgia.

CMS data shows 80 Medicare services from Dr. Hritani across 4 procedure codes in 2024, for 78 Medicare patients. Medicare paid $3,870 for them.

CMS counts 78 Medicare patients who saw Dr. Hritani in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hritani's median patient age at 74, with 58% women.

In 2024, Dr. Hritani wrote 38 Medicare Part D claims for 23 patients. 76% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $175 in total drug cost. In 2018, CMS named 31 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Hritani for performance year 2024, reported through an alternative payment model (APM). Dr. Hritani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Hritani, published from 2014 to 2022. 2018 was the busiest year, with 2. Dr. Hritani's most frequent co-authors are Ahmad Alkaddour, MD, Kenneth John Vega, MD and Wael Adnan Aljaroudi, MD.

CMS Open Payments shows 83 general payments to Dr. Hritani from 18 drug and device companies from 2020 to 2025. Travel and lodging make up the largest share, 49% of the total. Abbott Laboratories paid the most, $3,982.